Publication: The evaluation of type 2 diabetes mellitus risk screening at community pharmacy setting
| dc.contributor.authors | Aygun, L.; Sari, H.; Okuyan, B.; Sancar, M. | |
| dc.date.accessioned | 2022-03-10T18:00:27Z | |
| dc.date.accessioned | 2026-01-11T17:59:32Z | |
| dc.date.available | 2022-03-10T18:00:27Z | |
| dc.date.issued | 2020 | |
| dc.identifier.doi | doiWOS:000526320100052 | |
| dc.identifier.eissn | 2210-7711 | |
| dc.identifier.issn | 2210-7703 | |
| dc.identifier.uri | https://hdl.handle.net/11424/222290 | |
| dc.identifier.wos | WOS:000526320100052 | |
| dc.language.iso | eng | |
| dc.publisher | SPRINGER | |
| dc.relation.ispartof | INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | The evaluation of type 2 diabetes mellitus risk screening at community pharmacy setting | |
| dc.type | conferenceObject | |
| dc.type.sub | meetingabstract | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 226 | |
| oaire.citation.issue | 1 | |
| oaire.citation.startPage | 226 | |
| oaire.citation.title | INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | |
| oaire.citation.volume | 42 |
